Yahoo Web Search

  1. The drugmaker has been working to retain its position as a leader in diabetes care with newer drugs like Trulicity, Jardiance and Basaglar, as its top-selling insulin product Humalog ...

  2. Top Stock Reports: Disney, Eli Lilly, ADP & More

    Zacks via Yahoo FinanceAug 08 15:21 PM

    Disney's third-quarter fiscal 2019 results were hurt by investments in ESPN+ and Disney+, and consolidation actions related to 21st Century Fox (21CF) and Hulu. The Zacks ...

  3. Q2 Earnings Preview For Eli Lilly

    Benzinga via Yahoo FinanceJul 29 18:37 PM

    Eli Lilly (NYSE: LLY) releases its next round of earnings this Tuesday, July 30. Here's Benzinga's essential guide to Eli Lilly's Q2 earnings report. Eli Lilly ...

  4. Eli Lilly and Co reported a second-quarter profit that topped Wall Street estimates and raised its 2019 earnings forecast on Tuesday, as higher demand for newer drugs ...

  5. Eli Lilly Reports Q2 Earnings Beat

    Benzinga via Yahoo FinanceJul 30 12:02 PM

    Eli Lilly (NYSE: LLY) reported quarterly earnings of $1.50 per share, which beat the analyst consensus estimate of $1.45 by 3.45%. This is unchanged from the same period last year ...

  6. Eli Lilly & Company LLY reported second-quarter 2019 adjusted earnings per share of $1.50, which beat the Zacks Consensus Estimate of $1.46. Lilly reported revenues ...

  7. Better Buy: Eli Lilly vs. GlaxoSmithKline

    Motley Fool via Yahoo FinanceAug 18 11:28 AM

    Eli Lilly (NYSE: LLY) and GlaxoSmithKline (NYSE: GSK) are undergoing transformations. Eli Lilly's second-quarter results provide a pretty good snapshot of ...

  8. 3 Lung Cancer Stocks That Could Soar in September

    Motley Fool via Yahoo FinanceAug 04 19:04 PM

    Eli Lilly (NYSE: LLY), Amgen (NASDAQ: AMGN), and AstraZeneca (NYSE: AZN) are scheduled to present hotly anticipated results that could expand their presence in this important ...

  9. Pfizer PFE and Sanofi SNY reported mixed...off its Upjohn unit and merge it with generic drugmaker Mylan to create a leading generic pharmaceutical company. Meanwhile, the ...

  10. Revenues, however, fell 16% year over year owing to loss of exclusivity for Adcirca and lower sales of Remodulin. Please note that United Therapeutics bought exclusive rights to commercialize ...

  1. Ads
    related to ELI LILLY AND COMPANY